Constructing a Standard of Care: Challenges in Pathways Development for Advanced Breast Cancer

Constructing a Standard of Care: Challenges in Pathways Development for Advanced Breast Cancer

On-Demand Webcast

This webcast is based on live proceedings from a symposium conducted at the 4th Annual Oncology Clinical Pathways Congress.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Faculty

Nicole M. Kuderer, M.D., M.S.(equiv)
CMO at Advanced Cancer Research Group
University of Washington, Seattle, WA

Intended Learners

This activity is designed for directors of oncology practice programs and cancer centers, oncologists, hematologists, commercial and government payers, pathway development executives, reimbursement specialists, specialty pharmacists, HEOR specialists, and other healthcare professionals interested in learning how to implement, integrate, and measure treatment pathways.

Learning Objectives
  • Discuss obstacles to treatment selection after second-line therapy for patients with MBC
  • Describe the pharmacological profiles of novel and emerging MBC agents, including their indications, potential place in therapy, and recent clinical data.
  • Review patient and disease characteristics informing individualized treatment selection and sequencing
  • Evaluate strategies to address the challenges of cost-effective MBC treatment.
  • Develop MBC pathways that address the needs of all stakeholders, including clinicians
Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10 question post-test with a score of 70% or better, and complete the evaluation form.

After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Participants who completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: December 10, 2019
Expiration Date: December 10, 2020

Estimated time to complete: 0.75 hours

For questions regarding this educational activity, please call 609-371-1137.

There is no fee associated with this activity.

ACPE Credit Policy 
Your official record of ACPE credit will be generated through the CPE Monitor System. The certificate printed from this website after completing the evaluation for this activity is for personal tracking purposes only.

Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended. Please note that you must complete the activity evaluation within 60 days of a live activity or within 60 days of beginning the evaluation for an enduring activity. Under ACPE Policy, NACCME will not be able to report your activity completion to CPE Monitor after this 60-day period.

Accreditation

  In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CME

NACCME designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 credit(s).

PAs should only claim credit commensurate with the extent of their participation.


CNE

This continuing nursing education activity awards 0.75 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 0.75 contact hours.

CPE

This activity is approved for 0.75 contact hours (0.075 CEU) of continuing pharmacy education
(UAN JA0006201-0000-19-168-H01-P / JA0006201-0000-20-003-H01-P).

This educational activitiy is a knowledge-based activity.

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Senior Manager, Accreditation and Compliance, NACCME, in writing at 104 Windsor Center Drive, Suite 200, East Windsor, NJ 08520. The Senior Manager, Accreditation and Compliance will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation and Compliance, NACCME, may be made for a second level of review.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs (please download here). A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Planning Committee

The planning committee comprises: Nicole M. Kuderer, M.D., M.S.(equiv), Susie Seaman, NP, James Stevenson, MD; Chris Bolwell, Jennifer Browne, Molly Duda, Mary Johnson, Amanda Mulder, Todd Kunkler, Jennifer Ilycn, Randy Robbin, Shannon Stevenson, and Joanna Tong, from NACCME.

Independent Clinical Reviewer: James Stevenson, MD, Vice-Chairman, Department of Hematology/Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Kuderer has disclosed:Research consultant for: Janssen, Bayer, Pfitzer, Halozyme, Amgen, Mylan, Agendia, Genomic Health, Spectrum. Member of ASCO Guidelines and NCCN Guidelines. No speakers bureau engagements. No direct stocks of any pharmaceutical or medical companies. 

Ms. Seaman: Advisory Board—Mölnlycke

Jennifer Browne, Molly Duda, Mary Johnson, Amanda Mulder, Todd Kunkler, Jennifer Ilycn, Randy Robbin, Shannon Stevenson, and Joanna Tong from NACCME have disclosed no relevant financial relationships with any commercial interests.

Chris Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individualís consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgement must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

This session is supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., Eisai, Merck, Novartis Pharmaceuticals Corporation and Seattle Genetics.